144 related articles for article (PubMed ID: 12569083)
41. Effects of phosphotyrosine phosphatase inhibition on insulin secretion and intracellular signaling events in rat pancreatic islets.
Gogg S; Chen J; Efendic S; Smith U; Ostenson C
Biochem Biophys Res Commun; 2001 Feb; 280(4):1161-8. PubMed ID: 11162649
[TBL] [Abstract][Full Text] [Related]
42. Independent signal-transduction pathways for vanadate and for insulin in the activation of glycogen synthase and glycogenesis in rat adipocytes.
Sekar N; Li J; He Z; Gefel D; Shechter Y
Endocrinology; 1999 Mar; 140(3):1125-31. PubMed ID: 10067835
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of cardiac glucose transport by thioctic acid and insulin.
Ramrath S; Tritschler HJ; Eckel J
Horm Metab Res; 1999 Dec; 31(12):632-5. PubMed ID: 10668913
[TBL] [Abstract][Full Text] [Related]
44. Effect of inhibitors and activators of tyrosine kinase on insulin imprinting in Tetrahymena.
Kovács P; Csaba G
Cell Biochem Funct; 1992 Dec; 10(4):267-71. PubMed ID: 1473267
[TBL] [Abstract][Full Text] [Related]
45. Vanadate stimulation of adenylyl cyclase: an index of tyrosine kinase vascular effects.
Tan CM; McDonald CG; Chorazyczewski J; Burry AF; Feldman RD
Clin Pharmacol Ther; 1999 Sep; 66(3):275-81. PubMed ID: 10511063
[TBL] [Abstract][Full Text] [Related]
46. Vanadate augments insulin binding and prolongs insulin action in rat adipocytes.
Fantus IG; Ahmad F; Deragon G
Endocrinology; 1990 Dec; 127(6):2716-25. PubMed ID: 2249624
[TBL] [Abstract][Full Text] [Related]
47. Insulin and dexamethasone stimulation of cardiac lipoprotein lipase activity involves the actin-based cytoskeleton.
Ewart HS; Severson DL
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):485-90. PubMed ID: 10333493
[TBL] [Abstract][Full Text] [Related]
48. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4).
Lu B; Ennis D; Lai R; Bogdanovic E; Nikolov R; Salamon L; Fantus C; Le-Tien H; Fantus IG
J Biol Chem; 2001 Sep; 276(38):35589-98. PubMed ID: 11463798
[TBL] [Abstract][Full Text] [Related]
49. Vanadate inhibits glucose output from isolated perfused rat liver.
Bruck R; Prigozin H; Krepel Z; Rotenberg P; Shechter Y; Bar-Meir S
Hepatology; 1991 Sep; 14(3):540-4. PubMed ID: 1874499
[TBL] [Abstract][Full Text] [Related]
50. The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo.
Strout HV; Vicario PP; Saperstein R; Slater EE
Endocrinology; 1989 Apr; 124(4):1918-24. PubMed ID: 2647469
[TBL] [Abstract][Full Text] [Related]
51. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response.
Fantus IG; Ahmad F; Deragon G
Diabetes; 1994 Mar; 43(3):375-83. PubMed ID: 7508873
[TBL] [Abstract][Full Text] [Related]
52. Activation of Akt during simulated ischemia/reperfusion in cardiac myocytes.
Mockridge JW; Marber MS; Heads RJ
Biochem Biophys Res Commun; 2000 Apr; 270(3):947-52. PubMed ID: 10772931
[TBL] [Abstract][Full Text] [Related]
53. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
Westergaard N; Brand CL; Lewinsky RH; Andersen HS; Carr RD; Burchell A; Lundgren K
Arch Biochem Biophys; 1999 Jun; 366(1):55-60. PubMed ID: 10334863
[TBL] [Abstract][Full Text] [Related]
54. Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action.
Bernier M; Laird DM; Lane MD
J Biol Chem; 1988 Sep; 263(27):13626-34. PubMed ID: 2458350
[TBL] [Abstract][Full Text] [Related]
55. Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes.
Elberg G; He Z; Li J; Sekar N; Shechter Y
Diabetes; 1997 Nov; 46(11):1684-90. PubMed ID: 9356013
[TBL] [Abstract][Full Text] [Related]
56. Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1.
Elrick LJ; Docherty K
Diabetes; 2001 Oct; 50(10):2244-52. PubMed ID: 11574405
[TBL] [Abstract][Full Text] [Related]
57. Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic rats.
Cordera R; Andraghetti G; DeFronzo RA; Rossetti L
Endocrinology; 1990 Apr; 126(4):2177-83. PubMed ID: 2156685
[TBL] [Abstract][Full Text] [Related]
58. Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake.
Tsiani E; Abdullah N; Fantus IG
Am J Physiol; 1997 Jan; 272(1 Pt 1):C156-62. PubMed ID: 9038821
[TBL] [Abstract][Full Text] [Related]
59. Vanadate has no effect on insulin-extraction by the rat liver.
Bruck R; Melzer E; Karasik A; Krepel Z; Bar-Meir S
Horm Metab Res; 1994 Aug; 26(8):360-2. PubMed ID: 7806130
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3).
Maestro B; Molero S; Bajo S; Dávila N; Calle C
Cell Biochem Funct; 2002 Sep; 20(3):227-32. PubMed ID: 12125099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
